Study: Medicaid costs still growing faster than state revenues

NewsGuard 100/100 Score

A new study from the National Governors Association and the National Association of State Budget Officers paints a mixed picture -- at best -- of state budgets.

The Washington Post: States Face Bleak Economic Forecast, Report Says
The report says that Medicaid, the combined federal-state health program for the poor and the disabled, will place the biggest budgetary burden on states. Because of increasing caseloads, declining federal help and spiraling health-care costs, state Medicaid spending is growing much faster than state revenue, crowding out funding for other priorities (Fletcher, 11/29).

The Wall Street Journal: State Budgets Improve Slowly
While revenue is projected to continue growing with the economy, albeit slowly, the cuts will likely continue because states' costs-;in particular their costs for Medicaid, the state and federal health-care program for the needy-;continue to outpace the growth in tax revenue (LaHart, 11/29).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Critical questions raised for evaluation of anti-amyloid immunotherapies in Alzheimer's treatment